Celltrion

From WikiMD's WELLNESSPEDIA

File:Celltrion logo.png
Celltrion logo

Celltrion is a South Korean biopharmaceutical company headquartered in Incheon, South Korea. It was founded in 2002 by Jung Jin Seo. The company specializes in the development, manufacturing, and marketing of biosimilars and biopharmaceuticals. Celltrion is known for its innovative approach to biotechnology and has made significant contributions to the global healthcare industry.

History[edit]

Celltrion was established in 2002 with the aim of developing biosimilars, which are biologic medical products highly similar to already approved reference products. The company quickly gained recognition for its high-quality biosimilars and expanded its operations globally.

Products[edit]

Celltrion's product portfolio includes a range of biosimilars and biopharmaceuticals. Some of the notable products include:

Research and Development[edit]

Celltrion invests heavily in research and development (R&D) to innovate and improve its product offerings. The company operates state-of-the-art R&D facilities and collaborates with various academic and research institutions to advance its biopharmaceutical technologies.

Global Presence[edit]

Celltrion has a strong global presence, with subsidiaries and partnerships in various countries. The company exports its products to numerous markets, including the United States, Europe, and Asia. Celltrion's global expansion strategy focuses on increasing accessibility to affordable biosimilars and improving healthcare outcomes worldwide.

Awards and Recognition[edit]

Celltrion has received numerous awards and accolades for its contributions to the biopharmaceutical industry. The company is recognized for its commitment to quality, innovation, and patient care.

See Also[edit]

References[edit]


External Links[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Celltrion&oldid=5896854"